Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Study Number: 

I 210611

Phase: 
III
Trial categories: 
Multiple Myeloma
Bone Marrow (BMT)
Immunotherapy
Principal Investigator: